logologo
QuantliQuantli

BioMarin Pharmaceutical Inc

BMRN

NASDAQ

Biotechnology

$67.36

USD

-1.17 (-1.71%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $13.35B

Volume 1.4M

Price Target

$60.00$114.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $114.00 and a min estimate of $60.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$82.25

-$8.0 vs prior

Implied Upside

+22.1%

-11.8% vs prior

Analyst Covering

4

-9 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

24%

Many ratings are older - consensus may be less current

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$4.75 Gap

Median $77.50 vs avg $82.25 - a few bullish outliers are pulling the average up

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

3 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

3

Hold

1

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Whitney Ijem

Canaccord Genuity

Buy

Maintained

6 days ago

Plus
Plus
Plus

Mitchell S. Kapoor

HC Wainwright & Co.

Hold

Maintained

1 week ago

Plus
Plus
Plus

Eric Joseph

JP Morgan

Buy

Initiated

2 months ago

Plus
Plus
Plus

Jason Zemansky

B of A Securities

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

NBIX

Neurocrine Biosciences Inc

$152.72

+1.3%

SMMT

Summit Therapeutics Inc

$13.35

-4.6%

UTHR

United Therapeutics Corp

$499.73

-0.3%

BBIO

BridgeBio Pharma Inc

$79.86

-1.7%

ARWR

Arrowhead Pharmaceuticals Inc

$86.64

+1.2%

EXEL

Exelixis Inc

$51.24

+1.2%

MDGL

Madrigal Pharmaceuticals Inc

$507.56

+0.0%

HALO

Halozyme Therapeutics Inc

$98.66

-2.0%

INCY

Incyte Corp

$120.16

-0.3%